Walleye Trading’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,124
| Closed | -$429K | – | 4119 |
|
|
2026
Q1 | $410K | Buy |
5,124
+900
| +21% | +$74.2K | ﹤0.01% | 2710 |
|
|
2025
Q4 | $360K | Buy |
+4,224
| New | +$347K | ﹤0.01% | 3035 |
|
|
2025
Q3 | – | Sell |
-11,664
| Closed | -$911K | – | 4498 |
|
|
2025
Q2 | $912K | Buy |
+11,664
| New | +$870K | ﹤0.01% | 2264 |
|
|
2024
Q3 | – | Sell |
-9,935
| Closed | -$722K | – | 4225 |
|
|
2024
Q2 | $918K | Sell |
9,935
-1,263
| -11% | -$112K | ﹤0.01% | 2133 |
|
|
2024
Q1 | $1.07M | Buy |
+11,198
| New | +$941K | ﹤0.01% | 2181 |
|
|
2023
Q4 | – | Sell |
-641
| Closed | -$44.6K | – | 5179 |
|
|
2023
Q3 | $44.4K | Buy |
+641
| New | +$51.5K | ﹤0.01% | 4232 |
|
|
2023
Q2 | – | Sell |
-7,914
| Closed | -$688K | – | 4826 |
|
|
2023
Q1 | $655K | Sell |
7,914
-20,215
| -72% | -$1.59M | ﹤0.01% | 2570 |
|
|
2022
Q4 | $2.1M | Buy |
28,129
+18,583
| +195% | +$1.43M | 0.01% | 1643 |
|
|
2022
Q3 | $789K | Buy |
9,546
+3,200
| +50% | +$308K | ﹤0.01% | 2456 |
|
|
2022
Q2 | $603K | Buy |
+6,346
| New | +$657K | ﹤0.01% | 2720 |
|
|
2022
Q1 | – | Sell |
-3,178
| Closed | -$357K | – | 5474 |
|
|
2021
Q4 | $412K | Buy |
3,178
+501
| +19% | +$58.4K | ﹤0.01% | 3146 |
|
|
2021
Q3 | $303K | Buy |
+2,677
| New | +$306K | ﹤0.01% | 3444 |
|
|
2021
Q1 | – | Sell |
-7,139
| Closed | -$604K | – | 4932 |
|
|
2020
Q4 | $651K | Buy |
+7,139
| New | +$592K | ﹤0.01% | 2417 |
|
|
2020
Q2 | – | Sell |
-8,976
| Closed | -$638K | – | 4331 |
|
|
2020
Q1 | $564K | Buy |
8,976
+720
| +9% | +$51.9K | ﹤0.01% | 1785 |
|
|
2019
Q4 | $642K | Buy |
+8,256
| New | +$645K | ﹤0.01% | 2196 |
|
|
2019
Q1 | – | Sell |
-26,094
| Closed | -$1.49M | – | 4361 |
|
|
2018
Q4 | $1.33M | Sell |
26,094
-56,061
| -68% | -$2.84M | 0.01% | 1414 |
|
|
2018
Q3 | $4.77M | Buy |
82,155
+51,162
| +165% | +$2.5M | 0.03% | 682 |
|
|
2018
Q2 | $1.5M | Sell |
30,993
-390
| -1% | -$18.2K | 0.01% | 1653 |
|
|
2018
Q1 | $1.46M | Sell |
31,383
-9,831
| -24% | -$427K | 0.01% | 1543 |
|
|
2017
Q4 | $1.55M | Buy |
41,214
+22,782
| +124% | +$836K | 0.01% | 1528 |
|
|
2017
Q3 | $672K | Buy |
18,432
+10,428
| +130% | +$398K | ﹤0.01% | 2209 |
|
|
2017
Q2 | $315K | Sell |
8,004
-13,230
| -62% | -$483K | ﹤0.01% | 2769 |
|
|
2017
Q1 | $666K | Sell |
21,234
-49,374
| -70% | -$1.55M | ﹤0.01% | 1999 |
|
|
2016
Q4 | $2.21M | Buy |
70,608
+32,247
| +84% | +$1.04M | 0.02% | 896 |
|
|
2016
Q3 | $1.54M | Buy |
+38,361
| New | +$1.44M | 0.01% | 1184 |
|
|
2016
Q2 | – | Sell |
-45,015
| Closed | -$1.54M | – | 5431 |
|
|
2016
Q1 | $1.32M | Buy |
45,015
+12,510
| +38% | +$345K | 0.01% | 1155 |
|
|
2015
Q4 | $856K | Buy |
+32,505
| New | +$844K | 0.01% | 1385 |
|
|
2015
Q3 | – | Sell |
-20,514
| Closed | -$495K | – | 5108 |
|
|
2015
Q2 | $487K | Buy |
20,514
+10,038
| +96% | +$227K | ﹤0.01% | 1686 |
|
|
2015
Q1 | $249K | Buy |
+10,476
| New | +$235K | ﹤0.01% | 2027 |
|
|
2014
Q2 | – | Sell |
-41,832
| Closed | -$567K | – | 3799 |
|
|
2014
Q1 | $517K | Buy |
41,832
+16,788
| +67% | +$194K | 0.01% | 1268 |
|
|
2013
Q4 | $274K | Sell |
25,044
-45,966
| -65% | -$518K | ﹤0.01% | 1968 |
|
|
2013
Q3 | $824K | Buy |
71,010
+55,878
| +369% | +$654K | 0.01% | 966 |
|
|
2013
Q2 | $169K | Buy |
+15,132
| New | +$179K | ﹤0.01% | 1774 |
|
Other funds holding EW
Walleye Trading's EW Position: Q2 2026 in Review
Walleye Trading sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 5,124 shares — an estimated $429K sold.
Walleye Trading first reported a position in EW in Q2 2013 and held it in 33 quarters. The position peaked at $4.77M in Q3 2018. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Walleye Trading reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 5,124 Edwards Lifesciences shares in Q2 2026, an estimated $429K.
- Walleye Trading first reported a position in Edwards Lifesciences in Q2 2013 and held it in 33 quarters.
- Walleye Trading's Edwards Lifesciences position peaked at $4.77M in Q3 2018.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.